Hemera
  • Company
    • About us
    • Team
    • Job opportunities
  • Cell therapy
    • REMaST®️
    • Preclinical results
    • Clinical trials
    • Publications
  • Newsroom
    • Highlights
    • News and events
    • Videos
    • Interviews
  • Investors
  • English
    • Italiano (Italian)
Select Page

The importance of scientific communication: Cristiana Vignoli interviewed by Touchpoint on the REMaST® challenge

Apr 1, 2026 | News, Press Review

Touchpoint, an editorial publication focused on the intersection between markets and innovation, dedicated a feature in its February–March print edition to Hemera, including an interview with Cristiana Vignoli, Chief Executive Officer of the company. The interview...

REMaST® and the publication in Immunity: growing media attention on the therapeutic platform and its clinical development potential

Mar 27, 2026 | News, Press Review

In January 2026, following the dissemination of the scientific preprint on the cell therapy REMaST published in the international scientific journal Immunity by Cell Press,Hemera received significant national media coverage, confirming the growing interest in...

Osservatorio Terapie Avanzate features Hemera and the regenerative medicine challenge behind REMaST®

Mar 23, 2026 | News, Press Review

Hemera is featured in an article published by Osservatorio Terapie Avanzate, a leading Italian editorial platform focused on scientific information and analysis of innovations in advanced therapies, regenerative medicine, and biotechnology. In the interview, Cristiana...

Hemera Selected to Pitch at European Deeptech Week in Paris at Women in Biotech Panel

Mar 18, 2026 | Events, News

Hemera was selected to present its scientific and entrepreneurial journey at the European Deeptech Week in Paris, one of Europe’s leading events dedicated to scientific and technological innovation, organized by Bpifrance and co-hosted with European initiatives such...

National Television TG4 Medicina Features Hemera’s Research: Interview with Ilaria Decimo

Mar 15, 2026 | News, Videos

The research developed by Hemera was featured in the TG4 Medicina, an in-depth health and innovation program within the national news broadcast of Rete 4 dedicated to medical and scientific topics. The interview featured Ilaria Decimo, Co-Founder and Director of...

Hemera’s research featured on Radio 24: regenerative medicine and new perspectives for spinal cord injuries

Mar 10, 2026 | News, Press Releases

The research of Hemera was featured on the Smart City podcast on Radio 24, dedicated to scientific and technological innovation, in an interview with Ilaria Decimo, co-founder and Director of Research & Development at Hemera. The episode addressed one of the most...
« Older Entries

Follow us on social:

  • Follow
  • Follow
  • Follow

HÊMERA SRL

Via Giovanni della Casa, 26
37122 Verona – Italy
VAT IT04819260235
REA: VR – 448793
Mail: info@hemerapharma.com
PEC: hemera@pec.it
Web: hemerapharma.com

OPERATIONAL HEADQUARTERS VERONA

Dipartimento di Diagnostica e Sanità pubblica. Palazzina Medicina Legale – Farmacologia – CIRSAL.

Piazzale L. Scuro, 10 – 37134 Verona (VR)

OPERATIONAL HEADQUARTERS MILAN

Dipartimento di Biotecnologie Mediche e Medicina Traslazionale – BIOMETRA. Laboratorio Interdisciplinare di Tecnologie Avanzate (LITA).

Via Fratelli Cervi, 93 – 20054 Segrate (MI)

Privacy Policy | Cookies policy | Modifica preferenze
Copyright Hemera Srl © 2026
FAQ | Contacts